APA (7th ed.) Citation

Yu, X., Robbie, G. J., Wu, Y., Esser, M. T., Jensen, K., Schwartz, H. I., . . . Jafri, H. S. (2017). Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults. Antimicrobial agents and chemotherapy, 61(1), . https://doi.org/10.1128/AAC.01020-16

Chicago Style (17th ed.) Citation

Yu, Xiang-Qing, Gabriel J. Robbie, Yuling Wu, Mark T. Esser, Kathryn Jensen, Howard I. Schwartz, Terramika Bellamy, Martha Hernandez-Illas, and Hasan S. Jafri. "Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus Aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults." Antimicrobial Agents and Chemotherapy 61, no. 1 (2017). https://doi.org/10.1128/AAC.01020-16.

MLA (9th ed.) Citation

Yu, Xiang-Qing, et al. "Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus Aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults." Antimicrobial Agents and Chemotherapy, vol. 61, no. 1, 2017, https://doi.org/10.1128/AAC.01020-16.